阅读说明：本技术 2,6-二氨基吡啶化合物 (2, 6-diaminopyridine compound ) 是由 T·B·德拉姆 于 2019-08-29 设计创作，主要内容包括：本发明提供式I的化合物或其药学上可接受的盐,以及式I化合物用于治疗代谢病症,如2型糖尿病、心力衰竭、糖尿病性肾病和非酒精性脂肪性肝炎的用途：式I。(The present invention provides compounds of formula I, or pharmaceutically acceptable salts thereof, and the use of compounds of formula I for the treatment of metabolic disorders, such as type 2 diabetes, heart failure, diabetic nephropathy and non-alcoholic steatohepatitis:)